New combo may cut opioid use for cancer pain
NCT ID NCT05311774
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether adding duloxetine (a nerve pain drug) to tramadol (a painkiller) can better control chronic cancer pain and reduce the amount of tramadol needed. 400 adults with cancer pain who had not taken painkillers before were split into two groups: one received duloxetine plus tramadol, the other a placebo plus tramadol. The goal was to see if the combination leads to lower tramadol use while still managing pain effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut University
Asyut, 71111, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden risk: could opioid misuse be overlooked in cancer care?
- Could common painkillers boost opioid effectiveness for cancer patients?
- New Low-Dose pain patch aims to ease cancer suffering
- Radiosurgery zaps cancer pain when opioids fail
- Can video calls replace clinic visits for cancer pain?
- Massage therapy may ease painful sex after gynecological cancer